226 related articles for article (PubMed ID: 26082127)
1. Antibody Engineering.
Lo KM; Leger O; Hock B
Microbiol Spectr; 2014 Feb; 2(1):AID-0007-2012. PubMed ID: 26082127
[TBL] [Abstract][Full Text] [Related]
2. Current strategies in antibody engineering: Fc engineering and pH-dependent antigen binding, bispecific antibodies and antibody drug conjugates.
Vincent KJ; Zurini M
Biotechnol J; 2012 Dec; 7(12):1444-50. PubMed ID: 23125076
[TBL] [Abstract][Full Text] [Related]
3. The biotechnology and applications of antibody engineering.
Rapley R
Mol Biotechnol; 1995 Apr; 3(2):139-54. PubMed ID: 7620975
[TBL] [Abstract][Full Text] [Related]
4. Antibody engineering.
Maynard J; Georgiou G
Annu Rev Biomed Eng; 2000; 2():339-76. PubMed ID: 11701516
[TBL] [Abstract][Full Text] [Related]
5. Engineered antibodies take center stage.
Huston JS; George AJ
Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
[TBL] [Abstract][Full Text] [Related]
6. Trends in therapeutic antibody affinity maturation: From in-vitro towards next-generation sequencing approaches.
Tabasinezhad M; Talebkhan Y; Wenzel W; Rahimi H; Omidinia E; Mahboudi F
Immunol Lett; 2019 Aug; 212():106-113. PubMed ID: 31247224
[TBL] [Abstract][Full Text] [Related]
7. Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity.
Tustian AD; Endicott C; Adams B; Mattila J; Bak H
MAbs; 2016; 8(4):828-38. PubMed ID: 26963837
[TBL] [Abstract][Full Text] [Related]
8. Engineering antibodies for clinical applications.
Jain M; Kamal N; Batra SK
Trends Biotechnol; 2007 Jul; 25(7):307-16. PubMed ID: 17512622
[TBL] [Abstract][Full Text] [Related]
9. Antibody engineering for increased potency, breadth and half-life.
Sievers SA; Scharf L; West AP; Bjorkman PJ
Curr Opin HIV AIDS; 2015 May; 10(3):151-9. PubMed ID: 25760931
[TBL] [Abstract][Full Text] [Related]
10. Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair.
Strop P; Ho WH; Boustany LM; Abdiche YN; Lindquist KC; Farias SE; Rickert M; Appah CT; Pascua E; Radcliffe T; Sutton J; Chaparro-Riggers J; Chen W; Casas MG; Chin SM; Wong OK; Liu SH; Vergara G; Shelton D; Rajpal A; Pons J
J Mol Biol; 2012 Jul; 420(3):204-19. PubMed ID: 22543237
[TBL] [Abstract][Full Text] [Related]
11. Recent Developments Toward Antibody Engineering and Affinity Maturation.
Rathore AS; Sarker A; Gupta RD
Protein Pept Lett; 2018; 25(10):886-896. PubMed ID: 30255742
[TBL] [Abstract][Full Text] [Related]
12. Protein engineering of antibodies.
Sandhu JS
Crit Rev Biotechnol; 1992; 12(5-6):437-62. PubMed ID: 1423650
[TBL] [Abstract][Full Text] [Related]
13. Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA.
Larrick JW; Alfenito MR; Scott JK; Parren PW; Burton DR; Bradbury AR; Lemere CA; Messer A; Huston JS; Carter PJ; Veldman T; Chester KA; Schuurman J; Adams GP; Reichert JM
MAbs; 2016; 8(8):1425-1434. PubMed ID: 27557809
[TBL] [Abstract][Full Text] [Related]
14. Generation of recombinant antibodies and means for increasing their affinity.
Altshuler EP; Serebryanaya DV; Katrukha AG
Biochemistry (Mosc); 2010 Dec; 75(13):1584-605. PubMed ID: 21417996
[TBL] [Abstract][Full Text] [Related]
15. Introduction to current and future protein therapeutics: a protein engineering perspective.
Carter PJ
Exp Cell Res; 2011 May; 317(9):1261-9. PubMed ID: 21371474
[TBL] [Abstract][Full Text] [Related]
16. Engineering therapeutic monoclonal antibodies.
Stone CA; Spiller BW; Smith SA
J Allergy Clin Immunol; 2024 Mar; 153(3):539-548. PubMed ID: 37995859
[TBL] [Abstract][Full Text] [Related]
17. In vitro antibodies: strategies for production and application.
Morrison SL
Annu Rev Immunol; 1992; 10():239-65. PubMed ID: 1590987
[TBL] [Abstract][Full Text] [Related]
18. Generation of dual-variable-domain immunoglobulin molecules for dual-specific targeting.
Gu J; Ghayur T
Methods Enzymol; 2012; 502():25-41. PubMed ID: 22208980
[TBL] [Abstract][Full Text] [Related]
19. Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014.
Larrick JW; Parren P; Huston JS; Plückthun A; Bradbury A; Tomlinson IM; Chester KA; Burton DR; Adams GP; Weiner LM; Scott JK; Alfenito MR; Veldman T; Reichert JM
MAbs; 2014; 6(5):1115-23. PubMed ID: 25517297
[TBL] [Abstract][Full Text] [Related]
20. Advances in Antibody Design.
Tiller KE; Tessier PM
Annu Rev Biomed Eng; 2015; 17():191-216. PubMed ID: 26274600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
